Ambrx Appoints Stephen Glover as Chairman of its Board of Directors
SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) — Ambrx Biopharma Inc., or Ambrx (NASDAQ:AMAM), today announced that Stephen Glover has joined the Company’s Board of Directors as Chairman. Mr. Glover has extensive experience building successful biopharmaceutical companies, with a focus on pharmaceutical business strategy, corporate development, product development, commercialization, and business optimization. The Company’s former Chair, Katrin Rupalla, Ph.D., has resigned from Ambrx’s Board of Directors to pursue another opportunity, which precludes her ability to serve on any boards of directors.